ABO809

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ABO809, covering 2024-10-02 to 2024-10-02. Get the full timeline:

Most recent: Clinical Trial Update: Study of Efficacy and Safety of ABO809 in Healthy Participants [Phase 1]